He currently works in the area of Bioinformatics, Systems Biology, and Drug Discovery. His research focuses onestablishing casual relationships between genotypes and phenotypes, and revealing mechanisms of action of existing and preclinical drugs. The primary goal is to bridge basic sciences with clinical research through developing and using tools derived from a broad area of computer sciences such as machine learning, computational geometry, graph theory, and imaging processing.